| Literature DB >> 29371155 |
Edoardo Errichiello1, Cristina Gorgone2, Loretta Giuliano3, Barbara Iadarola4, Emanuela Cosentino4, Marzia Rossato4, Nehir Edibe Kurtas5, Massimo Delledonne4, Teresa Mattina6, Orsetta Zuffardi5.
Abstract
SOX2 variants have been identified in multiple patients with severe ocular anomalies and pituitary dysfunction, in addition to various systemic features. We investigated a 26-year-old female patient suffering from spastic paraparesis, hypoplasia of corpus callosum, hypogonadotropic hypogonadism (HH) and intellectual disability, who was monitored for over 20 years, allowing a detailed genotype-phenotype correlation along time. Whole exome sequencing on the patient and her relatives identified a de novo SOX2 c.70del20 variant, which has been frequently reported in individuals with SOX2-related anophthalmia. Importantly, our patient lacked major ocular phenotype but showed vaginal agenesis, a feature never reported before. Although the involvement of male urogenital tract (cryptorchidism, hypospadias, small penis), is a well known consequence of SOX2 variants, their effect on the female genitalia has never been properly addressed, even considering the paradoxical female excess of SOX2 cases in the literature. Our findings emphasize the importance of testing for SOX2 variants in individuals with HH and genital anomalies even though anophthalmia or microphthalmia are not observed. Moreover, our case strengthens the role of SOX2 as a master regulator of female gonadal differentiation, as widely demonstrated for other SOX genes related to 46, XX sex reversal, such as SOX3 and SOX9.Entities:
Keywords: Anophthalmia/microphthalmia; Hypogonadotropic hypogonadism; Hypoplastic uterus; SOX2; Undetectable ovaries; Vaginal agenesis
Mesh:
Substances:
Year: 2018 PMID: 29371155 DOI: 10.1016/j.ejmg.2018.01.011
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708